Professional medical societies are committed to providing trustworthy clinical practice guidelines (CPGs) that summarize evidence-based clinical practices for their members, and for the patients that they serve. In response to evolving national and medical specialty society standards, the Institute of Medicine (IOM) and the Council of Medical Specialty Societies (CMSS) have issued carefully considered, detailed recommendations about how these CPGs should be prepared and communicated to the public.1,2 It is important to note that they include recommendations regarding conflict of interest (COI). The American Academy of Dermatology (AAD), as the largest specialty society of dermatologists, takes seriously the development of dermatology CPGs, including the management of COI. In light of the recommendations from the IOM and CMSS, the AAD has revised and continues to refine its approach to directly and transparently address potential COI in CPG development and to limit the participation of those who may introduce bias into evidence-based methods.
Lim HW, Elmets CA, Begolka WS. Addressing Potential Conflicts of Interest in Dermatology Clinical Practice Guidelines. JAMA Dermatol. 2018;154(3):259–260. doi:10.1001/jamadermatol.2017.6207
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.